Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study.

Title:: Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study.
Document type:: Meeting Abstract
Author(s):: Jeremic, B; Milicic, B; Acimovic, L; Milisavljevic, S
Journal title abbreviation:: J Clin Oncol
Year:: 2004
Journal volume:: 22 Suppl.
Journal issue:: 14
Pages contribution:: 657S-657S
Language:: eng
Print-ISSN:: 0732-183X
TUM Institution:: Klinik und Poliklinik für RadioOnkologie und Strahlentherapie
BibTeX

Occurrences: